1. Home
  2. EDBL vs LNAI Comparison

EDBL vs LNAI Comparison

Compare EDBL & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EDBL

Edible Garden AG Incorporated

BUY

Current Price

$0.83

Market Cap

1.8M

ML Signal

BUY

LNAI

Lunai Bioworks Inc.

HOLD

Current Price

$0.29

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDBL
LNAI
Founded
2020
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8M
2.1M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
EDBL
LNAI
Price
$0.83
$0.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 145.8K
99.9K
Earning Date
11-13-2026
10-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.85
EPS
N/A
★ N/A
Revenue
★ $12,810,000.00
$51,992.00
Revenue This Year
$24.00
N/A
Revenue Next Year
$282.47
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.08
$0.22
52 Week High
$17.30
$5.02

Technical Indicators

Market Signals
Indicator
EDBL
LNAI
Relative Strength Index (RSI) 20.26 14.77
Support Level $0.44 $0.22
Resistance Level $1.20 $1.65
Average True Range (ATR) 0.06 0.16
MACD -0.00 -0.04
Stochastic Oscillator 10.81 4.49

Price Performance

Historical Comparison
EDBL
LNAI

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces. Company provides two principal product segments: (i) fresh produce, including cut herbs, hydroponic basil, potted herbs, and wheatgrass; and (ii) shelf-stable and refrigerated consumer packaged goods, including sports nutrition and nutraceuticals.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is an AI-driven biotechnology company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or lifelong cancer remission in some of the deadliest cancers. The Group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. Its reportable segments are BioSymetrics, which derives the maximum revenue, and RENB. Geographically, the Group operates in the United States and Canada.

Share on Social Networks: